NeoGenomics Laboratories Tech Stack

Cancer diagnostics lab network with NGS, cytogenetics, and pathology services

Hospitals and Health Care Fort Myers, Florida 1,001–5,000 employees Founded 2002 Public Company

NeoGenomics operates a multi-site CAP/CLIA laboratory network focused on oncology diagnostics, processing samples across cytogenetics, FISH, molecular genetics, NGS, and immunohistochemistry. The tech stack reflects operational maturity (Oracle ERP, Salesforce, LIMS) paired with modern cloud infrastructure (Snowflake, Azure, AWS) — but the hiring mix tells a different story: healthcare staff dominates (123 roles), with only 10 engineering positions open, signaling that clinical operations and case throughput are the growth constraint, not engineering capacity.

Tech Stack 32 technologies

Core StackSalesforce Snowflake AWS Terraform CloudFormation AWS Lambda Jenkins GitHub Actions Azure DevOps CloudWatch Datadog Splunk Active Directory Microsoft Office LIMS Oracle ERP Word PowerPoint Excel Sanger sequencing Outlook ICD-10 Azure AWS Direct Connect ExpressRoute Batch Glacier qPCR ddPCR

What NeoGenomics Laboratories Is Building

◆Challenges

Case delays
Expanding share of care
Missing billing information
Recurring billing errors
Reducing turnaround times
Reducing bad debt
Increasing test volume
Maintaining business
Burst compute for ai inference
Acquiring new customers

▲Active Projects

Next-generation sequencing clinical diagnostic assays
Implementation and support of lims
Mrd assay launch and growth
Automating secure, scalable hosting of image management systems
Fresh start program
Harmonizing diagnostic workflows across sites
Cloud-native digital pathology infrastructure
Case management monitoring program
Cytogenetics training program
High-volume ihc interpretation service

Hiring Activity

Steady220 roles · 80 in 30d

Department

Healthcare

123

Sales

Research

Logistics

Engineering

Ops

Support

Finance

Seniority

Junior

Mid

Senior

Manager

Director

Lead

Intern

Notable leadership hires: R&D Director, Marketing Director, Molecular Pathologist Laboratory Director, Regional Director, Project Director

Company intelligence

Find more companies like NeoGenomics Laboratories by tech stack, pain points and active projects

Get started free

About NeoGenomics Laboratories

NeoGenomics is a publicly traded cancer diagnostics company with laboratories across the United States and the United Kingdom. The company serves oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with testing menus spanning cytogenetics, flow cytometry, molecular genetics, NGS, and immunohistochemistry. Operations are structured around sample intake, analysis, and reporting — reflected in active work on NGS assay development, LIMS implementation, digital pathology infrastructure, and workflow harmonization across multiple sites. Revenue pressures are visible in concurrent focus on billing accuracy, bad-debt reduction, and case-delay mitigation.

HeadquartersFort Myers, Florida

Company Size1,001–5,000 employees

Founded2002

Hiring MarketsUnited States

Frequently Asked Questions

What diagnostic tests does NeoGenomics offer?

NeoGenomics specializes in oncology diagnostics including cytogenetics, FISH, molecular genetics, NGS, immunohistochemistry, and flow cytometry. Services span diagnostic and predictive testing across the cancer care continuum for oncologists, pathologists, hospitals, and pharma.

Where are NeoGenomics laboratories located?

NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories throughout the United States, plus a full-service sample-processing laboratory in Cambridge, England. Headquarters is in Fort Myers, Florida.